Fox Group have achieved a record-breaking year, with over 11,000 boxes of Seventy Hyal sold since its February launch, yet our innovation shows no sign of slowing down. We can’t wait to introduce our latest product development, harnessing the latest in cutting-edge aesthetic technology, with quality at the heart of everything we do.
We brought you the Next Generation Skin Booster, now get ready for…
aesPlla®: The Future of Restorative Injectables
What is aesPlla®?
aesPlla® is a bio-stimulatory PLLA injectable that offers intelligent rejuvenation, harnessing the skin’s natural collagen production to provide natural-looking volumisation with superior longevity.
Mr Apostolos Vlachogiorgos MD, MSc Plastic Reconstructive and Aesthetic Surgeon told Fox, “Although PLLA fillers are definitely not new in the industry, they are gradually becoming very popular alongside a large shift of the aesthetic industry edging towards more natural results.”
We listened to practitioners and learnt that finding the right PLLA product has not been without its challenges and aesPlla® was developed with these concerns in mind.
Thanks to its streamlined particle structure, the filler requires significantly less injection force than traditional PLLA fillers, for a smoother and more evenly dispersed treatment. The formula does not migrate or attract water, allowing precise injection, exactly where needed.
Thoroughly expert-tested, aesPlla® has no reported complications, greatly reducing the risk of nodules and granulomas that have been previously associated with traditional PLLA fillers.
Who is it suitable for?
aesPlla® is ideal for patients aged 30 and over, who are concerned with natural volume loss as a result of ageing or weight loss. Whilst hyaluronic acid fillers are ideal for sculpting and volumising specific areas of the face such as the lips, PLLA fillers offer a softer and more natural look, making them ideal for facial rejuvenation. The bio-stimulatory filler is designed to treat deeper dermal deficiencies and can be used to treat areas such as the marionette lines, cheeks and wrinkles. aesPlla® can also help to improve the appearance of atrophic scarring by stimulating new collagen production.
How does it work?
aesPlla® is formulated with PLLA or Poly-L-Lactic Acid, a material that has been used for over 20 years in dissolvable surgical stitches. This bio-compatible polymer biodegrades within the body, subsequently stimulating the natural production of new collagen to smooth and volumise the skin. aesPlla® requires three to four treatment sessions, spaced four weeks apart to achieve optimal results.
aesPlla® results will be visible from four weeks post-treatment, as the skin begins to produce new collagen. Initially, a renewed glow will be visible, followed by gradual volume restoration. The treatment results offer greater longevity than those of hyaluronic acid fillers, lasting for up to 3 years.
The Future of Restorative Injectables is here. aesPlla® is set to disrupt the PLLA market with an advanced formulation and notable safety profile. Offering visible volume restoration through collagen stimulation, our latest development harnesses intelligent rejuvenation to create natural-looking and long-lasting results. We can’t wait for you to try it.
Fox Group International are the exclusive UK rightsholders for The Nation’s Favourite Dermal Filler, REVOLAX and the official international rightsholders for The Next Generation Skin Booster, Seventy Hyal 2000. Fox Group International also sells a range of aesthetic supplies and pharmaceuticals to qualified medical professionals worldwide.